- Home
- MRK vs MVSTW Comparison
MRK vs MVSTW Comparison
Compare MRK & MVSTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- MVSTW
- Stock Information
- Founded
- MRK 2000
- MVSTW 2006
- Country
- MRK United States
- MVSTW United States
- Employees
- MRK N/A
- MVSTW 1921
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- MVSTW Industrial Machinery/Components
- Sector
- MRK Health Care
- MVSTW Miscellaneous
- Exchange
- MRK Nasdaq
- MVSTW Nasdaq
- Market Cap
- MRK 218.8B
- MVSTW N/A
- IPO Year
- MRK N/A
- MVSTW N/A
- Fundamental
- Price
- MRK $85.98
- MVSTW $0.43
- Analyst Decision
- MRK Buy
- MVSTW
- Analyst Count
- MRK 15
- MVSTW 0
- Target Price
- MRK $105.14
- MVSTW N/A
- AVG Volume (30 Days)
- MRK 10.0M
- MVSTW 126.0K
- Earning Date
- MRK 10-30-2025
- MVSTW 03-14-2025
- Dividend Yield
- MRK 3.77%
- MVSTW N/A
- EPS Growth
- MRK 58.06
- MVSTW N/A
- EPS
- MRK 7.56
- MVSTW N/A
- Revenue
- MRK $64,235,000,000.00
- MVSTW $370,989,000.00
- Revenue This Year
- MRK $1.76
- MVSTW N/A
- Revenue Next Year
- MRK $5.11
- MVSTW N/A
- P/E Ratio
- MRK $11.38
- MVSTW N/A
- Revenue Growth
- MRK 1.68
- MVSTW 39.03
- 52 Week Low
- MRK $73.31
- MVSTW $0.35
- 52 Week High
- MRK $105.07
- MVSTW $0.44
- Technical
- Relative Strength Index (RSI)
- MRK 51.00
- MVSTW 55.79
- Support Level
- MRK $83.30
- MVSTW $0.40
- Resistance Level
- MRK $88.30
- MVSTW $0.55
- Average True Range (ATR)
- MRK 1.67
- MVSTW 0.09
- MACD
- MRK -0.14
- MVSTW -0.01
- Stochastic Oscillator
- MRK 50.06
- MVSTW 27.23
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About MVSTW Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.